CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $1.2M of Cerevel Therapeutics Holdings, Inc.
Sold$1,203,415
$24.07Price
50,000Shares
−95%Stake
What CERE did after the filing
- The stock from Fri, Sep 8 close, $24.18
- −5.9%
- S&P 500, same days
- −5.1%
Measured over 30 trading days, to the Oct 20 close.
Traded Thu, Sep 7. Filed Fri, Sep 8, 12:35 PM ET, during the session. Returns use the Sep 8 close and the Oct 20 close. Not investment advice.